HRL

Business profile & competitive position

Hormel Foods Corporation operates in the Consumer Defensive sector, specifically Packaged Foods. It develops, processes, markets, and distributes branded food products—primarily meat and nuts—through three reportable segments: Retail, Foodservice, and International. Its portfolio includes household names such as Planters®, SPAM®, Jennie-O®, Skippy®, Applegate®, and Hormel® Black Label®, sold via the company’s own sales force, brokers, distributors, common carriers, and company-operated delivery systems.

The business model carries meaningful customer concentration. In fiscal 2025, Walmart accounted for 15.6% of consolidated gross sales less returns and allowances, and the top five customers collectively represented roughly 38%. That concentration gives large retail partners significant negotiating leverage and means Hormel’s volumes and shelf placement are closely tied to a handful of buyers. On the margin side, net margin is 2.8% and return on equity is 4.3%. Those figures are modest for a company with a broad branded portfolio, suggesting that while the brands provide consumer recognition, the competitive moat has not translated into strong pricing power or capital efficiency in the current environment. The Retail segment includes the MegaMex Foods joint venture, and the International segment includes equity-method investments, royalty arrangements, and operations in China and Brazil, adding geographic and partnership complexity to the profit mix.

Financial posture

Hormel currently carries a market capitalization of $10.9 billion and trades at a trailing P/E of 31.5. Net margin is 2.8%, ROE is 4.3%, and beta is 0.32, indicating low market sensitivity consistent with a defensive consumer staples name. At the current snapshot price of $19.825, the stock sits below its 50-day EMA of $22.24, and the RSI reads 25.3, technically in oversold territory.

The valuation multiple is notable relative to the profitability figures. A P/E of 31.5 alongside a sub-3% net margin and 4.3% ROE implies the market is either underwriting a meaningful earnings recovery or pricing in the company’s dividend reliability rather than near-term growth. The low beta confirms the stock is less volatile than the overall market, but the gap between valuation and current returns highlights why recent commentary has framed the shares as offering an attractive yield while facing growth struggles.

Strategic priorities & outlook

Hormel’s most recent 10-K filing outlines a strategy centered on high-quality, strongly branded products backed by reliable customer service, with the goal of supporting a higher value proposition. The company emphasizes meeting customer and consumer preferences, driving product innovation, and maintaining long-term relationships with industry partners. Operationally, it is executing strategic initiatives including the Transform and Modernize initiative and a recent corporate restructuring plan.

On the cost side, Hormel is actively managing raw material cost and availability risk through supply contracts, long-term supply agreements, forward buying, and futures/options/swaps hedging. Principal raw materials include pork, turkey, beef, chicken, and nuts. The company buys hogs for its Austin facility, raises most of its turkeys, and supplements long-term pork contracts with spot-market purchases. This commodities-heavy input base, combined with the customer concentration noted earlier, means execution on pricing, hedging, and supply-chain planning is central to the outlook.

Macro & geopolitical exposure

As a Packaged Foods company built on protein and nut products, Hormel sits at the intersection of several macro and geopolitical channels. Livestock commodity prices, feed costs, and grain markets directly affect input expenses for pork, turkey, beef, and chicken. Animal disease events—such as avian influenza in turkey flocks—can constrain supply and raise costs. Trade policy matters because pork and nut exports are exposed to tariffs and retaliatory measures, while the International segment’s operations in China and Brazil introduce currency-translation and regional regulatory risk. Broader supply-chain reliability, food-safety regulation, and a shift among value-seeking consumers toward private-label alternatives also shape the operating environment for branded packaged foods.

Recent developments

Recent headlines capture the crosscurrents investors are weighing. On September 28, 2026, Seeking Alpha published “Hormel: Undervalued And A Record Yield But Facing Growth Struggles,” framing the stock as an income story with top-line challenges. A September 26, 2026 Seeking Alpha article, “Best Dividend Kings: September 2026,” placed Hormel in the context of long dividend-raising streaks. On September 25, 2026, Zacks asked “Can Hormel Foods' Protein Portfolio Win Over Value-Seeking Consumers?,” highlighting the company’s effort to align its protein lineup with budget-conscious shoppers. Earlier, on September 23, 2026, 247wallst ran “Hormel Foods vs General Mills: One Dividend Rests on Solid Cash, the Other on Fumes,” drawing a direct comparison on dividend sustainability.

Taken together, the news flow underscores a central tension: Hormel is viewed as a durable dividend name with a record yield, but analysts and commentators are questioning whether the protein portfolio can reignite growth and whether cash generation can comfortably support the payout.

Earnings behavior & post-earnings drift

Hormel has beaten earnings expectations in 5 of the last 8 reported quarters, a 62% beat rate, with an average earnings surprise of 1.3%. However, the average 5-day price move after earnings across those quarters was -0.95%, producing a classified “down” post-earnings drift. In other words, even when results exceed the official consensus, the stock has tended to give back ground over the following week.

The last four quarters illustrate the pattern. On August 27, 2026, Hormel reported actual EPS of $0.37 against an estimate of $0.3541, a 4.5% beat; the stock rose 1.36% the next day but only 1.88% over the following five days. On May 28, 2026, actual EPS of $0.40 beat the $0.3544 estimate by 12.9%, yet the stock fell 1.53% the next session and 1.27% over the next five days. The February 26, 2026 quarter delivered $0.34 versus $0.32, a 6.3% beat, producing a 3.14% one-day gain but a -2.54% five-day drift. On December 4, 2025, actual EPS of $0.32 beat the $0.3017 estimate by 6.1%, with the stock up 0.75% the next day but down 1.86% over the following five days.

The next scheduled report is December 3, 2026, before the market open, with a consensus EPS estimate of $0.38. With the stock already technically oversold at an RSI of 25.3 and trading below its 50-day EMA, the upcoming report may test whether Hormel can convert another potential beat into sustained price strength or whether the negative post-earnings drift persists.

For a deeper dive into HRL’s institutional ratings, consensus EPS revisions, and full analyst verdict, explore the platform’s complete institutional coverage on the ticker.